Emily Luo

Emily is one of our MD candidates who is interested in pursuing a career in orthopedic surgery. During her undergraduate career at Stanford University, she worked in the Gordon Li Lab studying the effects of Casein-Kinase 2 inhibition on medulloblastoma tumorigenesis, metastasis, and sensitivity to treatment. After graduating, she worked as a cell engineering research associate at Sana Biotechnology in South San Francisco and aided in developing their allogeneic CAR T-cell product and gene editing platforms. Since coming to Duke, her research in the Goodwin-Erickson Lab has been focused on elucidating the impact of opioid use on immunosuppression and patient outcomes.

In her free time, Emily enjoys coaching her 14s club volleyball team, taking her dog on long walks, lifting, and playing basketball.